Actein inhibits glioma growth via a mitochondria-mediated pathway

Insights

Black cohosh triterpene glycoside Actein inhibits glioma cell growth and colony formation. Actein induces apoptosis via the mitochondria-mediated pathway, suggesting potential therapeutic use for glioma.

Area of Science:

  • Pharmacology
  • Cancer Biology
  • Cell Biology

Background:

  • Black cohosh (Actea racemosa) contains triterpene glycosides, including Actein.
  • Previous research indicates Actein inhibits human breast cancer cell growth.
  • Glioma is a primary brain tumor with limited treatment options.

Purpose of the Study:

  • To investigate the anti-glioma effects of Actein.
  • To explore the underlying mechanisms of Actein's action on glioma cells.
  • To evaluate Actein's efficacy in a preclinical glioma model.

Main Methods:

  • In vitro studies using U87 and U251 human glioma cell lines.
  • Assessment of cell viability, colony formation, and apoptosis markers (Bax, Bcl-2, cleaved caspase-3, -9, PARP1).
  • In vivo xenograft mouse model to assess tumor growth inhibition.

Main Results:

  • Actein significantly inhibited glioma cell viability and colony formation in a dose- and time-dependent manner.
  • Actein induced apoptosis in glioma cells by modulating pro-apoptotic (Bax, cleaved caspase-3, -9, PARP1) and anti-apoptotic (Bcl-2) factors.
  • Actein suppressed tumor growth and induced apoptosis in a glioma xenograft model.

Conclusions:

  • Actein exhibits significant growth inhibitory effects on glioma cells.
  • Mitochondria-mediated apoptosis is a key mechanism underlying Actein's anti-glioma activity.
  • Actein demonstrates potential as a therapeutic agent for glioma treatment.

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.8K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
4.2K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.1K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.0K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.7K